2seventy bio, Inc. (NASDAQ:TSVT) Receives $7.20 Average PT from Brokerages
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and […]
Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have given a hold rating, two have assigned a buy rating and […]
